Insider Activity of Xu Cong Claire
According to the SEC Form 4 filings, Xu Cong Claire, being in a position of
- EVP, Clinical Development at NovaBridge Biosciences,оver the last 12 months, has bought 0 shares, and sold 11261 share for $20,351,over all time since 2026-06-01, has bought 0 shares, and sold 11261 share for $20,351.
Biography of Xu Cong Claire
No biography is available at this moment.